Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
31
CGEN Quote, Financials, Valuation and Earnings
Last price:
$1.60
Seasonality move
:
24.2%
Day range:
$1.54 - $1.61
52-week range:
$1.13 - $2.66
Dividend yield:
0%
P/E ratio:
55.83x
P/S ratio:
21.51x
P/B ratio:
3.44x
Volume:
209.6K
Avg. volume:
277K
1-year change:
1.26%
Market cap:
$150.6M
Revenue:
$27.9M
EPS (TTM):
-$0.30
Analysts' Opinion
-
Consensus RatingCompugen Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.25, Compugen Ltd. has an estimated upside of 288.2% from its current price of $1.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $1.61.
Fair Value
-
According to the consensus of 4 analysts, Compugen Ltd. has 288.2% upside to fair value with a price target of $6.25 per share.
CGEN vs. S&P 500
-
Over the past 5 trading days, Compugen Ltd. has overperformed the S&P 500 by 1.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Compugen Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Compugen Ltd. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Compugen Ltd. reported revenues of $1.9M.
Earnings Growth
-
Compugen Ltd. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Compugen Ltd. reported earnings per share of -$0.07.
Enterprise value:
67.5M
EV / Invested capital:
1.44x
Price / LTM sales:
21.51x
EV / EBIT:
3.52x
EV / Revenue:
9.77x
PEG ratio (5yr expected):
-0.08x
EV / Free cash flow:
-0.69x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
3.52x
Gross Profit (TTM):
$513K
Return On Assets:
-24.73%
Net Income Margin (TTM):
-400.1%
Return On Equity:
-51.8%
Return On Invested Capital:
-49.12%
Operating Margin:
-417.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $7.5M | $59.9M | $6.9M | $17.1M | $1.9M | |
| Gross Profit | $6.5M | $50.6M | $513K | $13.5M | $241K | |
| Operating Income | -$34.5M | $10.6M | -$32.2M | $4.5M | -$7.9M | |
| EBITDA | -$34.5M | $10.6M | -- | $4.5M | -- | |
| Diluted EPS | -$0.36 | $0.02 | -$0.30 | $0.01 | -$0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $112.3M | $91M | $60.3M | $114.8M | $88.9M | |
| Total Assets | $121.3M | $99.4M | $67.6M | $123.5M | $97.8M | |
| Current Liabilities | $15.3M | $14.8M | $10.4M | $27.8M | $20.3M | |
| Total Liabilities | $22.5M | $19.5M | $14.4M | $63M | $54M | |
| Total Equity | $98.8M | $79.8M | $53.2M | $60.5M | $43.8M | |
| Total Debt | $2.8M | $1.4M | $818K | $2.5M | $2.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2021-06-30 | 2022-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -$13.6M | -$20.7M | |
| Cash From Investing | -- | -- | -- | $13.4M | $20.2M | |
| Cash From Financing | -- | -- | -- | $909K | $353K | |
| Free Cash Flow | -$51.4M | -$49.9M | -$62.9M | -$13.8M | -$20.9M | |
CGEN
Sector
Market Cap
$150.6M
$28.4M
Price % of 52-Week High
60.53%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
0.01%
-1.32%
1-Year Price Total Return
1.26%
-22.19%
Beta (5-Year)
2.818
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.57
200-day SMA
Buy
Level
$1.57
Bollinger Bands (100)
Buy
Level
1.4 - 1.74
Chaikin Money Flow
Sell
Level
-1.9M
20-day SMA
Buy
Level
$1.60
Relative Strength Index (RSI14)
Sell
Level
49.69
ADX Line
Buy
Level
11.35
Williams %R
Neutral
Level
-42.2222
50-day SMA
Sell
Level
$1.69
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Sell
Level
-5.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.8715)
Sell
CA Score
(Annual)
Level (-0.8964)
Buy
Beneish M-Score
(Annual)
Level (-5.8499)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (1.3573)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Stock Forecast FAQ
In the current month, CGEN has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CGEN average analyst price target in the past 3 months is $6.25.
-
Where Will Compugen Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Compugen Ltd. share price will rise to $6.25 per share over the next 12 months.
-
What Do Analysts Say About Compugen Ltd.?
Analysts are divided on their view about Compugen Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Compugen Ltd. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Compugen Ltd.'s Price Target?
The price target for Compugen Ltd. over the next 1-year time period is forecast to be $6.25 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CGEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Compugen Ltd. is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CGEN?
You can purchase shares of Compugen Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Compugen Ltd. shares.
-
What Is The Compugen Ltd. Share Price Today?
Compugen Ltd. was last trading at $1.60 per share. This represents the most recent stock quote for Compugen Ltd.. Yesterday, Compugen Ltd. closed at $1.61 per share.
-
How To Buy Compugen Ltd. Stock Online?
In order to purchase Compugen Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CGEN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CGEN
Sector
P/E ratio
55.83x
23.66x
PEG ratio
-0.08x
-0.01x
P/B ratio
3.44x
1.84x
Price / LTM sales
21.51x
1.60x
Growth Metrics
CGEN
Sector
Revenue growth
-88.96%
4.85%
Earnings growth
-625.35%
11.15%
Revenue (5-year growth)
13.45%
6.45%
Earnings forecast
-$0.09
-$0.20
Profitability
CGEN
Sector
Profitability FY 2024
$19.9M
$3.6M
Return on invested capital
-49.12%
-30.98%
Return on assets
-24.73%
-27.62%
Return on equity
-51.8%
-36.69%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
9
Balance Sheet
CGEN
Sector
Total cash
$86.1M
$27.2M
Short term investments
$85M
$25.7M
Total assets
$115M
$79.9M
Long term debt
$2.5M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
44
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
